
The Gateway recombinational cloning system. (A) ORFs flanked by recombinational sites B1 and B2 are directionally cloned into a P1::ccdB::P2 Donor vector using the BP reaction. The resulting Entry clones are selected using the kanamycin-resistance marker (Kmr). (B) ORFs flanked by L1 and L2 sites are directionally transferred from Entry clones into R1::ccdB::R2 Destination vectors using the LR reaction. The resulting Destination clones are selected using the ampicillin resistance marker (Ampr). (C) Promoters flanked by recombinational sites B4 and B1r are directionally cloned into a P4::ccdB::P1r Donor vector using the BP reaction. The resulting Entry clones are selected using the kanamycin-resistance marker (Kmr). (D) ORFs flanked by L1 and L2 sites and promoters flanked by L4 and R1 are directionally transferred right adjacent to each other from their respective Entry clones into R4::ccdB::R2 Destination vectors using the LR reaction. The resulting Destination clones are selected using the ampicillin-resistance marker (Ampr).











